You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Efficient Lossless EEG Compression Engine
SBC: Alacron, Inc. Topic: N/AWe will develop an advanced lossless data compression engine for EEG, for use in telephone EEG transystems and digital EEG recording systems. While useful in rural and remote setting without ready acelectroencephalographers, and for home monitoring in selected patients with epilepsy and sleep distuavailable EEG telephone transmission systems restrict the number of channels of EEG transmitted andof ...
SBIR Phase I 1995 Department of Health and Human Services -
26-Hydroxycholesterol--Therapy for Ctx and Restenosis
SBC: ALBANY MOLECULAR RESEARCH, INC. Topic: N/A26-Hydroxycholesterol is a naturally occurring metabolic product derived from cholesterol. Recent isuggest that this metabolite plays a role as a feedback inhibitor of cholesterol synthesis and may bregulation of LDL receptors. The absence of 26-hydroxycholesterol has been postulated to be the molegenetic disease cerebrotendinous xanthomatosis. The discovery that this compound is produced in vascs ...
SBIR Phase I 1995 Department of Health and Human Services -
DISCOVERY OF CDK INHIBITORS AS ANTITUMOR AGENTS
SBC: ALBANY MOLECULAR RESEARCH, INC. Topic: N/AThe discovery of inhibitors of cyclin/cyclin dependent kinase (cdk) complexes is proposed which may have an antiprolifertive/antitumor effect of cells. Because overexpression of various cyclins have differential oncogenic potential, inhibitors will be assayed against a panel of cyclin/cdks. The goal of Phase I is to discover a compound which inhibits one or more cyclin/cdk complexes with a 10-fo ...
SBIR Phase I 1997 Department of Health and Human Services -
PORTABLE MULTIMEDIA FOR FAMILY CAREGIVER TRAINING
SBC: American Research Corporation of Virginia Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
ALKYLTRANSFERASE IN METASTATIC MALIGNANT MELANOMA
SBC: Applied Genetics, Inc. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
IDENTIFICATION OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGENS
SBC: Argonex, Inc. Topic: N/AIn the last several years there has been an explosion of information regarding the nature of peptide antigens expressed on human tumors together with class I molecules encoded in the Major Histocompatibility Complex (MHC) and recognized by cytotoxic T lymphocytes (CTL). One very successful approach aimed at the identification of these antigens, termed Direct Identification of Relevant Epitopes for ...
SBIR Phase I 1997 Department of Health and Human Services -
TACTILE GRAPHIC PRINTER PROJECT (TGPP)
SBC: Automated Functions, Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
ALGORITHM FOR 3D IMAGING OF THE EYE'S POSTERIOR POLE
SBC: LICKENBROCK TECHNOLOGIES, INC. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
DEVELOPMENT OF GENETICALLY HYPERTENSIVE DOGS
SBC: Butler Farms Usa, Inc. Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
SCREEN--REGULATOR OF HEMATOPOIETIC CELL RESTRICTED PTP1C
SBC: Cadus Pharmaceutical Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services